Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
- 3 February 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 28 (8), 1586-1595
- https://doi.org/10.1038/leu.2014.55
Abstract
To clarify the cooperative roles of recurrently identified mutations and to establish a more precise risk classification system in acute myeloid leukemia (AML), we comprehensively analyzed mutations in 51 genes, as well as cytogenetics and 11 chimeric transcripts, in 197 adult patients with de novo AML who were registered in the Japan Adult Leukemia Study Group AML201 study. We identified a total of 505 mutations in 44 genes, while only five genes, FLT3, NPM1, CEBPA, DNMT3A and KIT, were mutated in more than 10% of the patients. Although several cooperative and exclusive mutation patterns were observed, the accumulated mutation number was higher in cytogenetically normal AML and lower in AML with RUNX1-RUNX1T1 and CBFB-MYH11, indicating a strong potential of these translocations for the initiation of AML. Furthermore, we evaluated the prognostic impacts of each sole mutation and the combinations of mutations and/or cytogenetics, and demonstrated that AML patients could be clearly stratified into five risk groups for overall survival by including the mutation status of DNMT3A, MLL-PTD and TP53 genes in the risk classification system of the European LeukemiaNet. These results indicate that the prognosis of AML could be stratified by the major mutation status in combination with cytogenetics.Keywords
This publication has 44 references indexed in Scilit:
- Gene mutations of acute myeloid leukemia in the genome eraInternational Journal of Hematology, 2013
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Genetic profiling in acute myeloid leukaemia ─ where are we and what is its role in patient managementBritish Journal of Haematology, 2012
- The role of mutations in epigenetic regulators in myeloid malignanciesNature Reviews Cancer, 2012
- Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeBlood, 2011
- Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 StudyBlood, 2011
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem DuplicationJournal of Clinical Oncology, 2010
- Acquired mutations in TET2 are common in myelodysplastic syndromesNature Genetics, 2009
- Acute myeloid leukaemiaThe Lancet, 2006